Min Lu

Min Lu

Company: Morphic Therapeutics

Job title: Senior Director & Head of Fibrosis


Investigating How to Manipulate Metabolic Reprogramming for IPF Treatment 5:00 pm

An overview of the metabolic context of IPF Comprehensively analyzing the relationship between IPF patient phenotype and underlying metabolic disease Hearing how to address factors such as obesity, glucose intolerance, insulin resistance and diabetes in a pre-clinical setting for IPF drug developmentRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.